本页面由Tiger Trade Technology Pte. Ltd.提供服务

ARS PHARMACEUTICALS INC

5.32
-0.1850-3.36%
成交量:62.31万
成交额:328.68万
市值:5.29亿
市盈率:-2.45
高:5.46
开:5.40
低:5.20
收:5.51
52周最高:14.00
52周最低:4.91
股本:9,944.73万
流通股本:4,803.45万
量比:1.19
换手率:1.30%
股息:- -
股息率:- -
每股收益(TTM):-2.1757
每股收益(LYR):-1.7400
净资产收益率:-210.35%
总资产收益率:-48.02%
市净率:42.28
市盈率(LYR):-3.06

数据加载中...

2026/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/13

重要事件披露

Form 8-K - Current report
2026/07/28

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/17

重要事件披露

Form 8-K - Current report
2026/07/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/07

重要事件披露

Form 8-K - Current report
2026/06/25

重要事件披露

Form 8-K - Current report
2026/06/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/15

重要事件披露

Form 8-K - Current report
2026/05/13

重要事件披露

Form 8-K - Current report
2026/04/28

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]